Gilead Sciences, Inc. (GILD)
139.71
-0.59
(-0.42%)
USD |
NASDAQ |
Apr 02, 16:00
139.40
-0.31
(-0.22%)
After-Hours: 20:00
Gilead Sciences Profit Margin (Quarterly) : 27.44% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 13.47% |
| Biogen, Inc. | -2.24% |
| Johnson & Johnson | 20.83% |
| Arcellx, Inc. | -3.51K% |
| Moderna, Inc. | -121.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.72% |
| Return on Assets | 14.74% |
| Return on Invested Capital | 18.52% |
| Gross Profit Margin (Quarterly) | 79.65% |
| Operating Margin (Quarterly) | 37.64% |
| Return on Net Operating Assets | 21.66% |